Alzheimer disease market 2022

64 %
36 %
Information about Alzheimer disease market 2022
Business & Mgmt

Published on February 26, 2014

Author: NancyFreedman

Source: slideshare.net

Description

There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease.

PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2022 by GlobalData Explore all reports for “Alzheimer Drugs ” market @ http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/diseases-treatment/alzheimer-drugs . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2022 There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease. Key Questions Answered •How will the patent expiry of Aricept, Namenda, Razadyne/Reminyl, and Exelon patch affect the competitive landscape? •When will immunotherapies emerge and how will they affect the market? •What effect have changing regulations had on companies investing in the sector? •Who is the frontrunner in the drug pipeline for AD and what are its strengths and weaknesses? •Will pipeline drugs be able to compete with the AChEIs and NMDA receptor antagonists? •Where are companies investing R&D in 2013? •What will the market look like in the event of key pipeline failures? Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150294 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2022 Key Findings •The global AD therapeutics market is forecast to reach $6.49 billion by 2022 due to the launch of novel pipeline drugs and biologics. •All the leading branded therapies: Aricept, Namenda, Razadyne/Reminyl, and Exelon, will face their patent expiry during the forecast period. •By 2022, AD will be a crowded marketplace comprising a highly diversified field of therapies with individual drugs struggling to distinguish themselves. Complete report available @ http://www.rnrmarketresearch.com/pharmapoint-alzheimers-diseaseglobal-drug-forecast-and-market-analysis-to-2022-market-report.html . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2022 Scope •Annualized market revenues data for 9 key markets: US, France, Germany, Italy, Spain, UK, Japan, China, and India •Annualized market revenues data forecast from 2012 to 2022 •Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by the 9 key markets. Pipeline candidates fall under major therapeutic classes •Analysis of key recent licensing and partnership agreements in the AD therapeutics market •Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications •Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications. Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150294 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2022 Reasons to buy •Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. •Develop business strategies by understanding the trends shaping and driving the global market. •Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the market in future. •Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. •Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150294 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2022 For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

Add a comment

Related presentations

Related pages

Exelon (Alzheimer's Disease) - Forecast and Market ...

Exelon (Alzheimer's Disease) - Forecast and Market Analysis to 2022: Published: September 30, 2013: Content info: 62 Pages
Read more

Exelon (Alzheimer’s Disease) - Forecast and Market ...

Exelon (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 is a market research report available at US $3495 for a Single User PDF License from ...
Read more

Alzheimers Disease Market analysis and forecasts, 2007-2022

Alzheimers disease is the third leading cause of death in recent times and with an unprecedented patient potential, this disease area attracts awareness ...
Read more

TRx0237 (Alzheimer's Disease) - Forecast and Market ...

TRx0237 (Alzheimer's Disease) - Forecast and Market Analysis to 2022: Published: July 31, 2013: Content info: 83 Pages
Read more

Arimenda (Alzheimer's Disease) - Forecast and Market ...

Arimenda (Alzheimer's Disease) - Forecast and Market Analysis to 2022. Table of Contents. 1 Table of Contents 5 1.1 List of Tables 8 1.2 List of Figures 9
Read more

Alzheimer's Disease Market analysis and forecasts, 2007 ...

The Alzheimer’s Disease Market Analysis & Forecasts 2007-2022 report is a must ... 2007-2012, 2017 & 2022 Chart 5.20 Market Share for AD Agents in Spain ...
Read more